Researchers use CRISPR gene editing to improve red blood cell transfusion compatibility – Synthetic biologists have succeeded in generating laboratory-made red blood cells with rare blood group types that could one day be used to help patients who cannot be matched with donor blood.

http://www.bristol.ac.uk/news/2018/april/gene-editing-improves-red-blood-cell-transfusion-compatibility.html

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website, NutritionTheory.org

View all posts by Robert Zinn →